LNTH

#1282
Lantheus Holdings, Inc
83.0700 USD
+1.71%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
82.9500
83.0700
Rango anual
50.1550
84.3800
Cambio diario
+1.71%
Variación mensual
+3.84%
Variación en los últimos 6 meses
+48.18%
Cambio anual
+48.18%
Cierres anteriores
81.6700
Abrir
82.9500
Bid
Ask
Mínimo
82.9500
High
83.0700
Volumen
16
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 5.3668 B
  • Employee 1 193
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
19.52
Relación precio/flujo de caja
2.95

Lantheus Holdings Inc

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

Noticias